Femasys Inc. FEMY
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -88.11%
- 1 year
- -88.97%
- Open
- 1.33
- Prev close
- 1.36
- Mkt cap
- 11.47M
- Vol
- 95.12K
- Avg vol
- 733.87K
- EPS
- -3.28
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.31
- High
- 1.41
- Forward P/E
- -2.33
- Beta
- -2.83
- Short ratio
- 3.67
- Inst. own
- 7.26%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 1.14
- 200-d avg
- 1.22
- 1y target
- 8.25
5D chart
Signals (90)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 3:50 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 3:50 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 3:15 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 3:05 PM | 1 day ago |
| SMA: Bullish | Oct 30, 2:05 PM | 1 day ago |
| SMA: Bearish | Oct 30, 1:35 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:00 PM | 1 day ago |
| SMA: Bearish | Oct 30, 12:15 PM | 1 day ago |
| SMA: Bullish | Oct 30, 11:00 AM | 1 day ago |
| SMA: Bearish | Oct 30, 10:45 AM | 1 day ago |
| SMA: Bearish | Oct 30, 10:45 AM | 1 day ago |
| SMA: Bearish | Oct 30, 10:05 AM | 1 day ago |
| SMA: Bullish | Oct 30, 10:00 AM | 1 day ago |
| MACD: Buy Signal | Oct 30, 10:00 AM | 1 day ago |
| MACD: Sell Signal | Oct 30, 9:50 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:30 AM | 1 day ago |
| SMA: Bearish | Oct 29, 3:50 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:45 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 3:35 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:30 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 3:25 PM | 2 days ago |
| RSI: Oversold | Oct 29, 3:25 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 3:20 PM | 2 days ago |
| SMA: Bearish | Oct 29, 2:55 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 1:25 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 1:20 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:05 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:05 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 1:05 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:55 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:55 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 12:55 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 12:05 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 11:45 AM | 2 days ago |
| SMA: Bullish | Oct 29, 11:20 AM | 2 days ago |
| SMA: Bullish | Oct 29, 11:20 AM | 2 days ago |
| SMA: Bearish | Oct 29, 11:10 AM | 2 days ago |
| SMA: Bearish | Oct 29, 11:10 AM | 2 days ago |
| SMA: Bullish | Oct 29, 11:00 AM | 2 days ago |
| SMA: Bullish | Oct 29, 11:00 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:35 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:35 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 10:35 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:30 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 10:30 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:25 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 10:25 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 10:20 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:05 AM | 2 days ago |
| SMA: Bearish | Oct 29, 9:55 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 9:55 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:50 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 9:50 AM | 2 days ago |
| SMA: Bearish | Oct 29, 9:40 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 9:40 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:35 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 9:35 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 9:30 AM | 2 days ago |
| RSI: Overbought | Oct 28, 3:20 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 2:05 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 12:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 11:05 AM | 3 days ago |
| SMA: Bearish | Oct 28, 10:50 AM | 3 days ago |
| SMA: Bullish | Oct 28, 10:15 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 10:15 AM | 3 days ago |
| MACD: Sell Signal | Oct 27, 3:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 3:25 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:40 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:25 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 1:25 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:05 PM | 4 days ago |
| SMA: Bearish | Oct 27, 11:50 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 11:10 AM | 4 days ago |
| SMA: Bullish | Oct 27, 11:00 AM | 4 days ago |
| RSI: Oversold | Oct 27, 10:40 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 10:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 10:10 AM | 4 days ago |
| RSI: Oversold | Oct 26, 3:30 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 3:15 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 2:35 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:30 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:30 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:20 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:20 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 2:20 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 1:15 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 12:55 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:20 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:15 PM | 5 days ago |
News
2 days ago globenewswire.com
Femasys Appoints John Moorhead to Board of Directors
ATLANTA, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator developing transformative fertility and non-surgical permanent birth control solutions designed…
-
2 weeks ago benzinga.com
Femasys Doubles Number Of Enrolling Facilities To 12 In Its FemBloc FINALE Pivotal Study Across U.S.
Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator developing transformative fertility and non-surgical permanent birth control solutions designed to improve the standard of care, expand…
2 weeks ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Alaunos Therapeutics (NASDAQ:TCRT) shares rose 93.3% to $2.03 during Tuesday's pre-market session. The company's market cap stands at $2.6 million. Scinai Immunotherapeutics (NASDAQ:SCNI)…
-
1 month ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers DataMEDS AI (NASDAQ:MEDS) shares rose 124.1% to $3.63 during Wednesday's pre-market session. The company's market cap stands at $4.9 million. Tempest Therapeutics (NASDAQ:TPST) stock moved…
-
1 month ago benzinga.com
Femasys Files Prospectus Related To The Offer And Resale From Time To Time By The Selling Stockholders Of Up To An Aggregate Of 28,124,997 Shares Of Common Stock
https://www.sec.gov/Archives/edgar/data/1339005/000114036126035625/ny20081537x1_s3.htm
2 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 24.6% to $6.42 during Friday's regular session. The company's market cap stands at $10.3 million. Aethlon Medical (NASDAQ:AEMD) shares moved…
-
2 months ago benzinga.com
Femasys Partners With UNC Health To Introduce Fertility Diagnostics, FemVue And SpermVue, Together With Femaseed Complete Within UNC Health OB/GYN Practice Locations
-- For the first time, OB/GYNs within the UNC Health system will be able to offer women FemVue® fertility evaluation and FemaSeed as a first-line treatment option --ATLANTA, Aug. 26, 2026 (GLOBE…
2 months ago benzinga.com
Femasys Secures FDA Pathway for Non-Surgical Contraceptive
FDA clears modular PMA pathway for Femasys' FemBloc, an investigational non-surgical permanent birth control device for women in the US.
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers ZeroStack (NASDAQ:ZSTK) stock increased by 440.2% to $9.94 during Wednesday's regular session. The company's market cap stands at $4.4 million. Tenon Medical (NASDAQ:TNON) shares moved…
-
2 months ago benzinga.com
Femasys Q2 EPS $(1.08) Beats $(1.33) Estimate, Sales $756.716K Beat $730.667K Estimate
Femasys (NASDAQ:FEMY) reported quarterly losses of $(1.08) per share which beat the analyst consensus estimate of $(1.33) by 18.8 percent. This is a 66.25 percent increase over losses of $(3.20) per…
-
2 months ago benzinga.com
Maxim Group Maintains Buy on Femasys, Lowers Price Target to $10
Maxim Group analyst Jason McCarthy maintains Femasys (NASDAQ:FEMY) with a Buy and lowers the price target from $30 to $10.
-
2 months ago benzinga.com
Femasys Announces $30M Private Placement Led By New Investors And Members Of Management
Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator developing transformative fertility and non-surgical permanent birth control solutions designed to improve the standard of care, expand…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers China Pharma Holding (AMEX:CPHI) shares increased by 713.2% to $7.4 during Tuesday's regular session. The company's market cap stands at $36.8 million. Wellgistics Health (NASDAQ:WGRX) shares…
5 months ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
-
5 months ago benzinga.com
Femasys Announces CE Mark Approval For FemHSG Catheter, Further Expanding Its Portfolio In Europe Through Commercial Partners
Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today…
-
6 months ago benzinga.com
Femasys Announces First Revenue-Generating Commercial Use Of Its Fertility Portfolio In An OBGYN Setting, Led By FemaSeed As A First-Line Infertility Treatment
The procedure was supported by FemSperm®, enabling in-office sperm preparation and advancing the shift of fertility care to women's primary physician, where earlier intervention can improve access and
-
6 months ago benzinga.com
Femasys Collaborates With AMI Technologies To Roll Out, Commercialize Fertility Portfolio In Israel
Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced…
-
7 months ago benzinga.com
Femasys Appoints John Canning COO
Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced…
-
7 months ago benzinga.com
Femasys Q4 EPS $(0.06) Beats $(0.12) Estimate, Sales $813.387K Miss $1.450M Estimate
Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.12) by 47.83 percent. This is a 73.91 percent increase over losses of $(0.23) per…
-
7 months ago benzinga.com
Femasys Initiates Participant Enrollment In FINALE Pivotal Clinical Study Of FemBloc
Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced…
-
8 months ago benzinga.com
Lake Street Initiates Coverage On Femasys with Buy Rating, Announces Price Target of $1.5
Lake Street analyst Benjamin Haynor initiates coverage on Femasys (NASDAQ:FEMY) with a Buy rating and announces Price Target of $1.5.
-
8 months ago benzinga.com
Femasys' FemBloc Permanent Birth Control System Gets Certification Under Medical Device Single Audit Program
-- FemBloc becomes the latest Femasys product to achieve MDSAP certification, building on a proven track record of compliance --ATLANTA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY),…
-
8 months ago benzinga.com
Femasys Secures American Medical Association CPT Editorial Panel Approval For Category III CPT Code Covering Use Of FemaSeed For Intratubal Insemination
-- Advances reimbursement strategy in the U.S. for FemaSeed, an intended first-step infertility treatment --ATLANTA, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical…
-
9 months ago benzinga.com
Femasys Partners With OR Consulting Over Commercial Rollout Of Product Portfolio In Switzerland
Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced today a new…
-
9 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
-
9 months ago benzinga.com
Femasys Gets Nasdaq's 180-Day Extension Through July 13 To Regain Compliance
Femasys Inc. (NASDAQ: FEMY) ("Femasys" or the "Company"), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women…
-
9 months ago benzinga.com
Femasys Partners With Refuah Health Center To Offer FemaSeed As First Step In Infertility Treatment Process
Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced today a…
10 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
10 months ago benzinga.com
Why Multi Ways Holdings Shares Are Trading Higher By Around 60%; Here Are 20 Stocks Moving Premarket
Why Multi Ways Holdings Shares Are Trading Higher By Around 60%; Here Are 20 Stocks Moving Premarket
-
10 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
10 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
10 months ago benzinga.com
Femasys Receives 510(k) Clearance From FDA For FemVue Controlled Device, Diagnostic Solution For Controlled Contrast Delivery To Evaluate Fallopian Tube Status
-- Innovative single-device solution integrates proven FemVue and FemChec® technologies to support fallopian tube evaluation and improve workflow efficiency--ATLANTA, Dec. 18, 2025 (GLOBE NEWSWIRE)…
-
11 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
11 months ago benzinga.com
PharmaCyte Biotech Monetizes Femasys Stake; Cash And Securities Expected At ~$20M After Monetization, Up From $13.3M
PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company"), today announced the successful monetization of its stake in Femasys Inc. (NASDAQ:FEMY), further validating the Company's…
-
11 months ago benzinga.com
Laidlaw & Co. Initiates Coverage On Femasys with Buy Rating, Announces Price Target of $6.5
Laidlaw & Co. analyst Yale Jen initiates coverage on Femasys (NASDAQ:FEMY) with a Buy rating and announces Price Target of $6.5.
-
11 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
-
11 months ago benzinga.com
Femasys Q3 EPS $(0.10) Beats $(0.12) Estimate, Sales $729.394K Miss $1.450M Estimate
Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 13.04 percent. This is a 58.33 percent increase over losses of $(0.24) per…
-
11 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
-
11 months ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
1 year ago benzinga.com
Why AMD Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket
Why AMD Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
1 year ago benzinga.com
Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket